Epigenetic Silencing of Hepatitis B
3.6 Science And Tech, The Hindu, 2026-11-01
Henry Wheeler and Treat Johnson synthesised 5-methylcytosine in 1904; Robin Holliday and John Pugh in 1975 proposed methylation controls gene activity, now called epigenetics (term coined by Conrad Waddington, 1942). A paper in Nature Biomedical Engineering on September 21 reported CRMA-1001, an experimental therapy using a CRISPR-Cas9 locator and methylation effector, delivered on an mRNA platform, to silence hepatitis B viral DNA. In mice, 90% had undetectable viral DNA six months after three doses. It is a functional cure, not elimination; phase I/II clinical trial is ongoing.